BHC — Bausch Health Companies Share News
0.000.00%
Last trade - 00:00- $1.89bn
- $22.37bn
- $10.27bn
Canada Stocks: TSX rebounds from five-week low as Wall Street rallies
Canada Stocks: Energy and financials help lift Toronto market
Bausch Health jumps as Delaware court guards diarrhea drug's patent
Brief: Bausch Health Companies Inc Says Bausch Health (Excluding. B+L) Confirms 2023 Guidance
Brief: Bausch Health Companies Says CEO Thomas J. Appio's 2022 Total Compensation Was $13.2 Million Versus $10.2 Million In 2021 - SEC Filing
Factbox: US government to impose inflation penalties on 27 drugs
Brief: Richard De Schutter, Karabelas Notified Bausch Health To Retire From Board
Bausch Health Companies Inc expected to post earnings of 91cents a share - Earnings Preview
Bausch + Lomb rises as Brent Saunders returns as CEO
Bausch + Lomb to name Brent Saunders as CEO - WSJ (updated)
Brief: ARAZLO Now Available To Patients Through Provincial Public Drug Plans
Media: Bausch Health investors seek to block eye-care business spinoff - Bloomberg News
Unsubstantiated price hikes drove U.S. drug spending up $805 mln in 2021-report (updated)
NYSE ORDER IMBALANCE 90032.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 924102.0 SHARES ON BUY SIDE
India's Lupin rises on Brazilian unit acquiring rights to Bausch brands
NYSE ORDER IMBALANCE 54291.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 82174.0 SHARES ON SELL SIDE
NYSE ORDER IMBALANCE 66377.0 SHARES ON BUY SIDE